Post views: 1
A leading provider of premium medical cannabis and services, VIVO Cannabis Inc, (OTCMKTS: VVCIF) announced the strategic updates regarding its future for its shareholders on August 25th. In addition, the wholly owned license holder of the subsidiaries of Canna Farms and ABcann Medicals provides additional information on the direction of the company after July 5, 2021. In the previous reports, VIVO Cannabis has elected a new board of directors. It also announced the new boss
Executive Officer, Ray Laflamme, and since then, the company’s board of directors and management have been actively reinvigorating its business strategy.
The board of directors of VIVO Cannabis met to review the company’s proposed strategy. In addition, the company also looked into alternative options and announced that it would increase its focus on supporting medical retail, health and wellness. Additionally, the company is currently well positioned in the medical cannabis space as it has many assets. By enhancing these assets, the company expects to establish itself as a leading global medical company focused on making patients’ lives better.
VIVO way to profitability
VIVO Cannabis targets feedback from its medical stakeholders and patients, reducing operational costs, and integrating its business and operating systems for profitability. VIVO
Cannabis’ strong assets are Canna Farms and ABcann Medicinals, EU GMP certification, harvest medicine, patient care expertise, Germany, Australia and other international markets.
Statement from Ray Laflamme
Chief Executive Officer Ray Laflamme said they recognized their strengths and are committed to delivering value to their patients and shareholders by enhancing those strengths. He adds that they will continue to work together as a team and listen to the needs of patients, health professionals, advocacy groups and payor groups in national and global medical markets. With an increased and renewed focus on the core values of their medical channels, VIVO Cannabis once again commits to helping people as a top priority.
Canna Farms started as the first patient company from the start. This is an advancement to reaffirm their efforts given their success over the past six years. The company expects to continue recreational sales of core products to support consumers who purchase health and wellness products through these channels.